Call For Proposal: Validation of Fluid-Derived Biomarkers for the Prediction and Prevention of Brain Disorders

Validation of Fluid-Derived Biomarkers for the Prediction and Prevention of Brain Disorders

(HORIZON-HLTH-2024-DISEASE-03-two-stage)

Deadline model: Two Stage

Opening date: 26 April 2023

Deadline date: 19 September 2023 | 11 April 2024

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to most of the following expected outcomes:

  • The scientific and clinical communities make effective use of state-of-the-art information, data, technologies, tools and best practices to underpin the development of the diagnostics, and as such can also facilitate the development of effective therapeutics and/or preventive strategies.
  • The scientific and clinical communities advance the field through a better understanding of mechanisms underlying brain disorders at the molecular, cellular and systemic level.
  • The scientific and clinical community make wide use of newly established and where relevant open access databases and/or integrate them with existing infrastructures for storage and sharing of collected data according to FAIR[1] principles, thereby encouraging further use of the data.
  • Policymakers, funders, scientific and clinical communities, patient organisations, regulators and other relevant bodies are informed of the research advances made, while health professionals envisage use of the biomarker tests for early detection of the disorder and for guiding patients in the selection of personalised treatments/interventions.
  • Patients and caregivers are sufficiently engaged with the research, which also caters for their needs.

SCOPE:

Treatments for some high-burden brain disorders are potentially on the horizon[2]. Consequently, many patients and citizens will want to know if they are eligible for these treatments. For some disorders, a definitive diagnosis is difficult, expensive and time-consuming. Simple blood or other fluid-derived (e.g. saliva, urine, sweat) tests for markers that may indicate early signs of the disorder, and which can be deployed for widespread clinical use are needed.

The brain disorders within the scope of this topic fall under two categories, namely those listed under chapters six and eight of the International Classification of Diseases[3]. Proposals in the area of mental disorders are encouraged.

Kindly Apply:

Leave a Comment

Your email address will not be published. Required fields are marked *